Yoshiaki Kawamura Selected Research

Yoshiaki Kawamura Research Topics

Disease

11	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 07/2005
9	Infections 12/2018 - 01/2003
5	Neoplasms (Cancer) 03/2024 - 12/2011
5	Neoplasm Metastasis (Metastasis) 09/2020 - 12/2011
3	Carcinoma (Carcinomatosis) 11/2021 - 07/2014
3	Renal Cell Carcinoma (Grawitz Tumor) 09/2020 - 12/2011
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 02/2024 - 11/2020
2	Sarcopenia 11/2021 - 01/2021
2	Overactive Urinary Bladder (Overactive Bladder) 11/2020 - 10/2020
2	Inflammation (Inflammations) 01/2018 - 10/2005
2	Abscess 01/2017 - 08/2003
2	Bacteremia 05/2016 - 01/2007
1	Hernia (Hernias) 04/2024
1	Urinary Fistula 03/2024
1	Hypertrophy 02/2024
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2023
1	Iron Deficiencies 05/2021
1	Surgical Wound Infection 05/2021
1	Inguinal Hernia (Direct Inguinal Hernia) 01/2021
1	Erectile Dysfunction 10/2020
1	Periodontitis 03/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Endocarditis 03/2019
1	Ulcerative Colitis 01/2019
1	Lung Neoplasms (Lung Cancer) 10/2016
1	Guillain-Barre Syndrome 09/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2016
1	Sepsis (Septicemia) 05/2016
1	Coinfection 03/2015
1	Cough 07/2014
1	Urethritis 02/2013
1	Pseudomonas Infections 01/2012
1	Cystic Fibrosis (Mucoviscidosis) 01/2012
1	Hematuria 12/2011

Drug/Important Bio-Agent (IBA)

4	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 01/2003
2	SteroidsIBA 04/2024 - 09/2016
2	Interleukin-17 (Interleukin 17)IBA 03/2020 - 01/2018
2	16S Ribosomal RNAIBA 12/2018 - 03/2015
2	AminoglycosidesIBA 01/2016 - 01/2012
2	ApatitesIBA 08/2003 - 01/2003
1	Coloring Agents (Dyes)IBA 03/2023
1	IronIBA 05/2021
1	pyoverdinIBA 05/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	ThuliumIBA 11/2020
1	Immune Checkpoint InhibitorsIBA 09/2020
1	NivolumabIBA 09/2020
1	PerfumeIBA 03/2020
1	LipidsIBA 03/2020
1	NADH DehydrogenaseIBA 12/2019
1	Oxidoreductases (Dehydrogenase)IBA 03/2019
1	CatalaseIBA 03/2019
1	Hemoglobins (Hemoglobin)IBA 02/2019
1	cabazitaxel FDA Link 02/2019
1	Docetaxel (Taxotere)FDA Link 02/2019
1	Dextran SulfateIBA 01/2019
1	propionic acid (potassium propionate)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	CytokinesIBA 01/2018
1	Volatile Fatty AcidsIBA 01/2018
1	Interleukin-1 (Interleukin 1)IBA 01/2018
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2018
1	Butyric Acid (Butanoic Acid)IBA 01/2018
1	Meropenem (Merrem)FDA LinkGeneric 01/2017
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2017
1	PlatinumIBA 10/2016
1	Kanamycin FDA Link 10/2016
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 09/2016
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2016
1	AgarIBA 07/2014
1	cytolethal distending toxinIBA 04/2014
1	RNA (Ribonucleic Acid)IBA 04/2014
1	CholesterolIBA 04/2014
1	Shiga Toxin (Shigella Toxin)IBA 01/2014
1	QuinolonesIBA 02/2013
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2012
1	Amikacin (A.M.K)FDA LinkGeneric 01/2012
1	Recombinant ProteinsIBA 03/2008

Therapy/Procedure

6	Therapeutics 04/2024 - 09/2016
5	Prostatectomy (Retropubic Prostatectomy) 05/2024 - 01/2021
5	Nephrectomy 04/2024 - 12/2011
3	Drug Therapy (Chemotherapy) 10/2016 - 01/2014
3	Catheters 05/2016 - 12/2011
2	Aftercare (After-Treatment) 10/2020 - 01/2007
2	Castration 03/2020 - 02/2019
1	Conservative Treatment 03/2024
1	Operative Surgical Procedures 03/2024
1	Stents 03/2024
1	Nephroureterectomy 11/2021
1	Length of Stay 05/2021
1	Transrectal High-Intensity Focused Ultrasound 01/2021
1	Lasers (Laser) 11/2020
1	Radiotherapy 09/2020
1	Oral Administration 03/2020
1	Cystectomy 01/2020
1	Neoadjuvant Therapy 01/2020
1	Plasmapheresis 09/2016
1	Nebulizers and Vaporizers (Inhaler) 07/2014
1	Craniotomy 12/2011